Breast lumps are common in women. About 10% women visiting health organization clinics present with breast lumps as the chief complaint. 80-85% of breast lumps are benign and rests are malignant 1, 2, 3 . Breast carcinoma is the leading cause of cancer incidence and death in women. It is now the most common cancer both in developed and developing regions 4 . Early detection is the mainstay in management of breast carcinoma. FNAC is a routine procedure in clinical evaluation and initial diagnosis in breast lump worldwide 5 . Fine needle aspiration cytology has become an increasingly popular technique utilized in the diagnosis of palpable breast masses owing to its distinct advantages of being sensitive and specific, expedient, economical and safe. It is commonly used as a part of diagnostic triad, which in addition to the fine needle aspiration cytology includes clinical breast examination and imaging. In recent time the fine needle aspiration cytology has largely replaced excisional/incisional breast biopsy. Its distinct advantage is that it can be done during the outpatient visit without the need of the anesthesia, thus eliminating the cost of outpatient surgery. It also allows discussion with the patient of various treatment plans 
Introduction
Breast lumps are common in women. About 10% women visiting health organization clinics present with breast lumps as the chief complaint. 80-85% of breast lumps are benign and rests are malignant 1, 2, 3 . Breast carcinoma is the leading cause of cancer incidence and death in women. It is now the most common cancer both in developed and developing regions 4 . Early detection is the mainstay in management of breast carcinoma. FNAC is a routine procedure in clinical evaluation and initial diagnosis in breast lump worldwide 5 . Fine needle aspiration cytology has become an increasingly popular technique utilized in the diagnosis of palpable breast masses owing to its distinct advantages of being sensitive and specific, expedient, economical and safe. It is commonly used as a part of diagnostic triad, which in addition to the fine needle aspiration cytology includes clinical breast examination and imaging. In recent time the fine needle aspiration cytology has largely replaced excisional/incisional breast biopsy. Its distinct advantage is that it can be done during the outpatient visit without the need of the anesthesia, thus eliminating the cost of outpatient surgery. It also allows discussion with the patient of various treatment plans for malignant mass on the same visit. This has been confirmed by earlier several studies that aspiration cytology is superior to true-cut needle biopsy in establishing the diagnosis of clinically suspicious breast masses; however the sensitivity can be improved by increasing the number of core taken 6 . The purpose of this study is to evaluate our experiences with fine needle aspiration cytology in a series of patient and compare the diagnostic accuracy of fine needle aspiration cytology with postoperative histopathology. Accuracy of the needle tip in localizing the tumor in fine needle aspiration cytology was also studied by comparing the normal glandular cell aspirate with tumor cell aspirate.
Aims and Objectives
1. To find out the spectrum of benign and malignant lesions in all the FNAC performed and reported in cases presented with breast lump.
2. To compare the diagnostic accuracy of fine needle aspiration cytology in differentiating the benign and malignant lesions of palpable breast lump with histopathological correlation in all those cases where tissue biopsies were available.
Methods
The two years prospective study was conducted in the Department of Pathology, North Bengal Medical College, Sirajganj, Bangladesh from 1st January 2013 to 31st December 2014. During this period, 490 fine needle aspiration (FNA) were performed from various breast lumps. These 490 aspirations were obtained from breast masses of 484 patients. 6 patients had bilateral breast masses. Specimens were received from only 94 patients who underwent surgery in this and nearby hospitals, which formes the material for histopathological correlation.
Inclusion criteria: Among these FNAC cases, all available histopathology have been included to correlate with corresponding cytology diagnosis. In histopathology, all types of tissue biopsy viz. incisional biopsy, excisional biopsy, lumpectomy and mastectomy were included.
Exclusion criteria:
Those cases which were reported as inflamatory and supurrative lesion have been excluded from this study.
Methods of collection of the data:
In outpatient department a detailed history and thorough physical examination of the patient having palpable breast lump was carried out and entered in the proforma. The patient was informed about the procedure and informed consent was obtained from the patient before subjecting to fine needle aspiration cytology of the breast lump. Majority of the cases, 373 cases (76.12%) were found to be benign in contrast to 117 cases (23.87%) reported either as suspicious of carcinoma or as carcinoma. Among benign conditions, commonest cytology diagnosis was fibroadenoma (208 cases) followed by "proliferative breast disease" (123 cases). Among 490 total FNAC cases, 94 cases had undergone subsequent biopsy and follow up histopathology were available. Among 373 benign cases, 59 cases had histopathology correlation. In contrast, biopsy was available in 35 cases from 113 FNAC cases which were reported as "carcinoma" and in all 4 cases which were reported as "suspicious of malignancy" on FNAC (Figure-I ). In the present study, 490 aspirations were performed over a period of 2 years. 396 cases were lost to followup. Out of 490 patients, 94 cases were followed-up by histopathologic confirmation. These 94 cases were considered as the study group for the cytological and histopathological correlation of tumors of the breast.
Among 94 cases underwent for follow-up biopsy (Table-III (Table III) of the four FNAC suspicious carcinoma lesions, wide local excision biopsy done, the histopathology confirmed as infiltrating ductal carcinoma. Later all four cases underwent modified radical mastectomy on the same hospital admission, as we had no facility of intraoperative frozen section biopsy. There was no unsatisfactory (inadequate) sampling for malignant lesions. The results of the malignant lesions were as follows. Accuracy rate for malignant lesion was 92.10%, false negative rate was 7.90%. 
Discussion
Breast is an important and popular site for fine needle aspiration cytology. In 1984, wanebo et. al. suggested fine needle aspiration in place of open surgical biopsy for the diagnosis of breast cancer 7 . There is an increasing tendency to confirm the diagnosis of the breast cancer at first consultation by some form of needle biopsy technique. This allows better investigation and wiser preoperative discussion than was possible when excision biopsy and frozen section confirmed the clinical diagnosis. The present series confirms the accuracy and clinical utility of fine needle aspiration cytology in the investigation of the patient with benign and malignant breast disease. The accuracy of the diagnosis in patients with malignant breast disease is in the range of 85 to 90% in most of the series 6 .
In our study we had 373 benign lesions (76.12%) in FNAC, fibroadenoma being the most common benign lesion that presents for needle aspiration. This has been confirmed in other series also. Fibroadenoma form the 80% of the benign lesion aspirated for cytology. The fibroadenoma has been considered a significant cause for the false positive diagnosis. The over all activity of the epithelial cell in this tumor is probably the reason. We had no cases of false positive reports in our study.Breast carcinoma is one of the most common malignancies among women. The breast lump is usually discovered by the patient. In premenopausal women, up to 80% are benign; where as in patients over the age of 60 approximately 90% of the breast lumps are malignant. The fine needle aspiration cytology has become the investigation of choice for the diagnosis of the breast malignancy. The typical carcinoma presents a gritty resistance to the fine needle. The aspirate is usually copious and blood stained 6 . In our study we had Infiltrating ductal carcinoma being the most common malignant lesion in histopathology (Figure-III) . There was 1 case reported as lobular carcinoma in our study. Mainly diagnosed on histopathology, where as cytology was able to explain the presence of malignancy only. Lobular carcinoma can not be consistently differentiated from ductal carcinoma by cytology 8 . The present study confirms the accuracy and clinical utility of fine needle aspiration cytology in the management of benign and malignant breast diseases. The high rate of diagnostic accuracy and other predictive values in our study is similar to those in various other published series like the largest series conducted between 1982 and 2000 at Rush Presbyterian St. Lukes medical college Chicago, USA, where the sensitivity was 98%, specificity was 97%, positive predictive value was 99% and negative predictive value was 86% 9 . Between September 1992 and may 1996 another study was conducted in department of surgery, St Joseph hospital, Denever, Colorado and concluded that the use of fine needle aspiration cytology for solid breast lesion is accurate and cost effective with 100% positive predictive value, 100% specificity, 87% sensitivity and 89% negative predictive value 10 . This high rate of accuracy in fine needle aspiration cytology permitted us for definite preoperative planning and discussion with the patient in whom the fine needle aspiration is positive or suspicious for malignancy. In another prospective study, use of fine needle aspiration cytology and core biopsy in the diagnosis of breast cancer which was carried out on patients attending an open access breast clinic by Dennison, et al. concluded that fine needle aspiration cytology and core needle biopsy is complementary in the accurate diagnosis of the breast cancer 11 .
Fine needle aspiration cytology compliments clinical and radiological diagnosis; thus triple assessment has been reported to produce 99% accuracy for benign and malignant lesions. The diagnostic accuracy of clinical examination, mammography and fine needle aspiration cytology was compared with the definitive histological findings. Comparative study of all 3 diagnostic techniques in the diagnosis of breast tumor has shown that the accuracy of 99% can be achieved 12 . We had 3 false negative reports in our series. Although this can be regarded as a sampling error, the effect on management could be obvious. False negative rate in our series is 7.9%, which is comparable to various other series, which quoted false negative rate of 1 to 31% with average rage of 10% 13 . Great care must be taken to avoid false positive reports. Cellular fibroadenoma and papilloma bear a risk in this respect. (Figure-IV The accuracy of the needle tip in localizing the tumor in fine needle aspiration cytology was also studied in our series by comparing the normal glandular cell aspirate and inadequate aspitate with the tumor cell aspirate. The unsatisfactory (inadequate) sampling in which there was little or no cellular material reported, we believe, to be an error in the technique of aspiration. In our study we had twelve aspirations were reported as unsatisfactory, bringing the inadequate sampling rate to 2.45%. The unsatisfactory specimen rate for benign lesion was 3.22%, whereas for malignant lesion was 0%. The proportion of inadequate sampling as reported by different studies varies from 9 to 18% 14 . Our study result is comparable to study of Zarbo, et al. 14 who had reported that 17% of 2,254 aspirates in his institutional study were unsatisfactory for evaluation. Maintaining suction as the needle is withdrawn from the breast, leads to loss of cells in to the syringe at the time of withdrawal. This could probably be the common error done technically so as to produce an unsatisfactory material. Since inadequate sampling rate is 2.45%, the accuracy rate of needle tip in localizing the tumor in fine needle aspiration cytology is 97.55%. Repeat fine needle aspiration under ultrasound guidance was performed on the inadequate sampling specimen and that time it was reported as fibroadenoma, which was confirmed by histopathology after local excision.
By different studies also it has been concluded that accuracy of fine needle aspiration cytology in diagnosing the breast tumors increases by performing repeat aspiration in a lump for which previously been reported as inadequate sampling 14 16 . This is not surprising as the needle tract is invariably removed with definitive surgery.
The use of fine needle aspiration cytology as the main and direct indicator for mastectomy (without biopsy) remains controversial. The major concern is the danger of a false positive diagnosis, leading to unwarranted mastectomy. Since the false positive report is very rare (in our study it is zero), in the centers where the surgical staff is accustomed to performing mastectomy on the basis of fine needle aspiration cytology for diagnosis of cancer, there is necessary for a high level of confidence in and rapport with the cytopathologyst. The danger of misdiagnosis of a cancer is studiously avoided by maintaining a cautious and conservative threshold for diagnosing a cancer. Any questionable diagnosis that is stated to be suspicious, an open biopsy is suggested where in centers an intraoperative frozen section analysis is not available.
Conclusion
FNAC is well recognised for its high accuracy and efficacy rate in investigation of breast lumps. Recently the fine needle aspiration cytology has become an increasingly popular technique utilized in the diagnosis of palpable breast lumps owing to it distinct advantages of being sensitive, specific, expedient, economical and safe. False results especially false positive results are very rare which can be further minimized with proper clinical correlation. Thus it is commonly used as a part of diagnostic triad in case of breast lump, which in addition to fine needle aspiration cytology, includes clinical breast examination and imaging.
